To access this element change to forms mode OFF
Grant Award View - GA187304
The IC3 Trial: Identifying Cirrhosis and Liver Cancer in Primary Care
GA ID:
GA187304
Agency:
Department of Health and Aged Care
Approval Date:
23-Jun-2021
Publish Date:
30-Aug-2021
Category:
Health and Medical Research
Grant Term:
23-Jun-2021 to 31-Aug-2025
Value (AUD):
$3,192,950.55
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_EPCDR_Improving_Diagnosis_in_Cancers_Low_Survival_Rates
Grant Activity:
The IC3 Trial: Identifying Cirrhosis and Liver Cancer in Primary Care
Purpose:
Many patients with a common liver cancer, hepatocellular carcinoma (HCC), have undiagnosed cirrhosis. These patients have missed the opportunity for surveillance that could detect HCC earlier and improve survival. We have established an accurate cirrhosis detection pathway and aim to examine its effect and cost on early HCC diagnosis and HCC surveillance compared to usual care. 2800 patients will be recruited across rural and urban general practices in Australia for this study.
GO ID:
GO Title:
MRFF – EPCDR Initiative– 2020 Improving Diagnosis in Cancers with Low Survival Rates Grant Opportunity
Internal Reference ID:
MRF2009279
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Western Australia
Recipient ABN:
37 882 817 280
Grant Recipient Location
Suburb:
Nedlands
Town/City:
Nedlands
Postcode:
6009
State/Territory:
WA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, WA
Postcode:
Multiple
Country:
AUSTRALIA